Merck to Support SaudiVax in Becoming First Developer and Manufacturer of Halal Vaccines and Biotherapeutics in Saudi Arabia
Highlights: Merck has revealed its plans to assist SaudiVax Ltd., a Saudi Arabian-based company, in creating a top-quality manufacturing facility for biologics and vaccines for the MENA region. The project aims to support the localization of biologics and vaccine production in the region by developing a state-of-the-art manufacturing facility. Merck, being a leading science and technology company, will use its expertise in the biopharmaceutical industry to help SaudiVax in designing the facility to meet the highest standards. This project is a significant step towards achieving Saudi Arabia’s goals of localizing production and developing a robust healthcare sector, as well as providing accessible healthcare solutions for the MENA region.
Link to Original Article